Table 4.
n | AM | AMC | CF | CRO | E | AZM | NA | CIP | GM | SXT | TE | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Campylobacter coli | 3 | 33 | 100 | 0 | 33 | 33 | 100 | 33 | 33 | 100 | 0 | 100 |
Campylobacter jejuni | 16 | 56 | 100 | 38 | 13 | 88 | 100 | 25 | 25 | 100 | 0 | 44 |
Enteroaggregative Escherichia coli | 9 | 56 | 89 | 67 | 89 | 89 | 67 | 100 | 100 | 100 | 78 | 78 |
Enterotoxigenic E. coli* | 27 | 59 | 89 | 63 | 100 | 4 | 78 | 67 | 93 | 96 | 59 | 59 |
Shigella flexneri (Group B) | 4 | 50 | 75 | 25 | 100 | 0 | 100 | 100 | 100 | 100 | 25 | 0 |
Shigella sonnei (Group D) | 9 | 0 | 22 | 67 | 100 | 0 | 56 | 89 | 100 | 100 | 0 | 0 |
AM = ampicillin; AMC = amoxicillin/clavulanic acid; AZM = azithromycin; CF = cefalotin; CIP = ciprofloxacin; CRO = ceftriaxone; E = erythromycin; GM = gentamycin; NA = nalidixic acid; SXT = sulfamethoxazole/trimethoprim; TE = tetracycline.
Two different resistance patterns were detected in two of the 27 samples and included in the table (N = 27).